The use of nasal dilator strips as a placebo for trials evaluating continuous positive airway pressure

Aline C S Amaro, Felipe H G Duarte, Raquel S Jallad, Marcello D Bronstein, Susan Redline, Geraldo Lorenzi-Filho, Aline C S Amaro, Felipe H G Duarte, Raquel S Jallad, Marcello D Bronstein, Susan Redline, Geraldo Lorenzi-Filho

Abstract

Objectives: The aim of the current study was to compare the objective and subjective effects of continuous positive airway pressure to the use of nasal dilator strips in patients with acromegaly and moderate to severe obstructive sleep apnea.

Methods: We studied 12 patients with acromegaly and moderate to severe obstructive sleep apnea (male/ females = 8/4, age = 52 ± 8 ys, body mass index = 33.5 ± 4.6 Kg/m(2), apnea-hypopnea index = 38 ± 14 events/h) who had been included in a randomized, crossover study to receive three months of treatment with continuous positive airway pressure and nasal dilator strips. All patients were evaluated at study entry and at the end of each treatment by polysomnography, and Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index and treatment satisfaction questionnaires. ClinicalTrials.gov: NCT01265121

Results: The apnea-hypopnea index values decreased significantly with continuous positive airway pressure treatment but did not change with the use of nasal dilator strips. All of the subjective symptoms improved with both treatments, but these improvements were significantly greater with continuous positive airway pressure than with the nasal dilator strips.

Conclusion: The use of nasal dilator strips had a much smaller effect on the severity of obstructive sleep apnea in patients with acromegaly and moderate to severe obstructive sleep apnea in comparison to the use of continuous positive airway pressure. Moreover, the improvement in several subjective parameters without any significant objective improvement in obstructive sleep apnea resulting from the use of nasal dilator strips is compatible with a placebo effect.

Conflict of interest statement

No potential conflict of interest was reported.

References

    1. AASM. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep. 1999;22(5):667–89.
    1. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981;1(8225):862–5.
    1. Gay P, Weaver T, Loube D, Iber C. Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Sleep. 2006;29(3):381–401.
    1. Budhiraja R, Budhiraja P, Quan SF. Sleep-disordered breathing and cardiovascular disorders. Respiratory Care. 2010;55(10):1322–32; discussion 30-2.
    1. Ballester E, Badia JR, Hernandez L, Carrasco E, de Pablo J, Fornas C, et al. Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999;159(2):495–501.
    1. Engleman HM, Martin SE, Kingshott RN, Mackay TW, Deary IJ, Douglas NJ. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax. 1998;53(5):341–5.
    1. Redline S, Adams N, Strauss ME, Roebuck T, Winters M, Rosenberg C. Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy. Am J Respir Crit Care Med. 1998;157(3 Pt 1):858–65.
    1. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax. 1997;52(2):114–9.
    1. Farre R, Hernandez L, Montserrat JM, Rotger M, Ballester E, Navajas D. Sham continuous positive airway pressure for placebo-controlled studies in sleep apnoea. Lancet. 1999;353(9159):1154.
    1. Rodway GW, Weaver TE, Mancini C, Cater J, Maislin G, Staley B, et al. Evaluation of sham-CPAP as a placebo in CPAP intervention studies. Sleep. 2010;33(2):260–6.
    1. Kushida CA, Nichols DA, Quan SF, Goodwin JL, White DP, Gottlieb DJ, et al. The Apnea Positive Pressure Long-term Efficacy Study (APPLES): rationale, design, methods, and procedures. J Clin Sleep Med. 2006;2(3):288–300.
    1. Peltonen LI, Vento SI, Simola M, Malmberg H. Effects of the nasal strip and dilator on nasal breathing--a study with healthy subjects. Rhinology. 2004;42(3):122–5.
    1. Kirkness JP, Wheatley JR, Amis TC. Nasal airflow dynamics: mechanisms and responses associated with an external nasal dilator strip. Eur Respir J. 2000;15(5):929–36.
    1. Iber C A-IS, Chesson AL, Quan SF.The AASM Manual for the Scoring of Sleep and Associated Events, Rules, Terminology and technical Specifications American Academy of Sleep Medicine, Westchester, IL: AASM Manual for Scoring Sleep 2007
    1. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540–5.
    1. Buysse DJ, Reynolds CF, 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry research. 1989;28(2):193–213.
    1. Osorio CD, Gallinaro AL, Lorenzi-Filho G, Lage LV. Sleep quality in patients with fibromyalgia using the Pittsburgh Sleep Quality Index. J Rheumatol. 2006;33(9):1863–5.
    1. Elias RM, Castro MC, de Queiroz EL, Abensur H, Romao JE, Jr, Lorenzi-Filho G. Obstructive sleep apnea in patients on conventional and short daily hemodialysis. Am J Nephrol. 2009;29(6):493–500.
    1. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet. 1994;343(8897):572–5.
    1. Bahammam AS, Tate R, Manfreda J, Kryger MH. Upper airway resistance syndrome: effect of nasal dilation, sleep stage, and sleep position. Sleep. 1999;22(5):592–8.
    1. Hoijer U, Ejnell H, Hedner J, Petruson B, Eng LB. The effects of nasal dilation on snoring and obstructive sleep apnea. Arch Otolaryngol Head Neck Surg. 1992;118(3):281–4.
    1. Hoffstein V, Mateika S, Metes A. Effect of nasal dilation on snoring and apneas during different stages of sleep. Sleep. 1993;16(4):360–5.
    1. Ulfberg J, Fenton G. Effect of Breathe Right nasal strip on snoring. Rhinology. 1997;35(2):50–2.
    1. Todorova A, Schellenberg R, Hofmann HC, Dimpfel W. Effect of the external nasal dilator Breathe Right on snoring. Eur J Med Res. 1998;3(8):367–79.
    1. Krakow B, Melendrez D, Sisley B, Warner TD, Krakow J, Leahigh L, et al. Nasal dilator strip therapy for chronic sleep-maintenance insomnia and symptoms of sleep-disordered breathing: a randomized controlled trial. Sleep Breath. 2006;10(1):16–28.
    1. Gosepath J, Amedee RG, Romantschuck S, Mann WJ. Breathe Right nasal strips and the respiratory disturbance index in sleep related breathing disorders. Am J Rhinol. 1999;13(5):385–9.
    1. Scharf MB, Berkowitz DV, McDannold MD, Stover R, Brannen DE, Reyna R. Effects of an external nasal dilator on sleep and breathing patterns in newborn infants with and without congestion. J Pediatr. 1996;129(6):804–8.
    1. Schonhofer B, Wenzel M, Barchfeld T, Siemon K, Rager H, Kohler D. [Value of various intra- and extraoral therapeutic procedures for treatment of obstructive sleep apnea and snoring] Med Klin (Munich) 1997;92(3):167–74.
    1. Pevernagie D, Hamans E, Van Cauwenberge P, Pauwels R. External nasal dilation reduces snoring in chronic rhinitis patients: a randomized controlled trial. Eur Respir J. 2000;15(6):996–1000.
    1. Jenkinson C, Davies RJ, Mullins R, Stradling JR. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet. 1999;353(9170):2100–5.
    1. Scharf MB, Brannen DE, McDannold M. A subjective evaluation of a nasal dilator on sleep & snoring. Ear Nose Throat J. 1994. 1994;73(6):395–401.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera